WOCKHARDT
|
The Current P/B Ratio of WOCKHARDT is 6.12.
| Share Price | ₹1,856.1 | Oct 22,2026 |
| Market Cap | ₹30,161.6 Cr | |
| Book Value | ₹4,927.0 Cr | Mar2026 - Consolidated Results |
| Price/Book | 6.12x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of WOCKHARDT
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹30,161.6 Cr] as on Oct 22,2026
(/) Book Value [ ₹4,927.0 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 6.12x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '6.12 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WOCKHARDT !
The chart below summarizes the trend in P/B Ratio of WOCKHARDT over the last five years.
Historical PB (Price/Book ) ratio chart of WOCKHARDT
PB Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.70x.
- WOCKHARDT 's operated at median p/b ratio of 2.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/b ratio peaked in Mar2025 at 5.31x.
- WOCKHARDT 's p/b ratio hit its five-year low in Mar2023 of 0.66x.
How does WOCKHARDT 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| WOCKHARDT | 4,927.00 | 6.12 | 30,161.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.04 | 420,831.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 14.44 | 242,074.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 20.90 | 175,355.0 |
| CIPLA LTD | 34,369.40 | 3.13 | 107,439.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.74 | 103,417.0 |
| MANKIND PHARMA LTD | 16,252.60 | 5.79 | 94,042.1 |
| LUPIN LTD | 22,384.10 | 3.94 | 88,165.5 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.18 | 113,217.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.47 | 93,556.5 |
| LAURUS LABS LTD | 5,275.08 | 20.46 | 107,954.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WOCKHARDT 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.47x |
| Max industry PB | 20.90x |
| Median industry PB | 5.04x |
| Average industry PB | 8.11x |
You may also like the below Video Courses